This feasibility study will be used to assess the feasibility and acceptability of a hospice-embedded home transfusion program to patients with hematologic malignancies. All enrolled subjects will be patients cared for at Dana Farber Cancer Institute.~This study is a single-arm study of 10 patients with advanced hematologic malignancies who have a limited life-expectancy of six months or fewer and are hospice eligible.~10 Caregivers of enrolled patients will also be invited to participate if interested.~This research study involves completing questionnaires, a brief interview, blood draws, and blood transfusions when needed.~Participants will be in the research study for up to six months.~It is expected that about 20 people will take part in this research study.
The purpose of the research is to assess the feasibility and acceptability of a home blood transfusion program for patients with hematologic malignancies who need blood transfusions